Literature DB >> 23086329

Chromoblastomycosis in Mainland China: a systematic review on clinical characteristics.

Sha Lu1, Changming Lu, Junmin Zhang, Yongxuan Hu, Xiqing Li, Liyan Xi.   

Abstract

Chromoblastomycosis is one of the most frequent chronic infections caused by melanized fungi. In order to evaluate the clinical characteristics of chromoblastomycosis in Mainland China, we performed an evidence-based review of published literature. PubMed and Chinese-language database of CNKI, VIP and Wanfang data during January 1990-August 2011 were searched. Epidemiology, clinical features, laboratory findings, therapy and prognosis were analyzed. Cladophialophora carrionii was the most common causative agent in the north of the Mainland China, and Fonsecaea monophora and F. pedrosoi were the most common agents in the southern part of the Mainland China. Infection commonly initiated after the etiologic agents gain entrance through puncture wounds and more common involved extremities of the males. Skin lesions were found in different sites, like the extremities, buttocks, trunk and face, and presented diversity morphology. There were about seven different clinical types found in Mainland China: plaque type, tumoral type, cicatricial type, verrucous type, pseudo-vacuole type, eczymatous type and mixed type of lesions. The success of treatment for chromoblastomycosis was related to the causative agent, the clinical form and severity of the lesions. Most of the patients could be treated successfully with the physical treatment, chemotherapy and/or combination therapy. The itraconazole, terbinafine or a combination of both were commonly medication for these mycosis patients. Physical methods were usually indicated to support chemotherapy with some severe forms and long-lasting cases. Photodynamic therapy has been extended from the oncological field to that of antimicrobial chemotherapy in these years. We applied it on some recalcitrant cases of chromoblastomycosis and found its good clinical response, and hopeful it could be a promising therapy in near future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086329     DOI: 10.1007/s11046-012-9586-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  15 in total

1.  A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.

Authors:  Yabo Yang; Yongxuan Hu; Junmin Zhang; Xiqing Li; Changming Lu; Yuheng Liang; Liyan Xi
Journal:  Med Mycol       Date:  2012-02-07       Impact factor: 4.076

2.  Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora.

Authors:  Jun-Min ZHANG; Li-Yan XI; Hui ZHANG; Zhi XIE; Jiu-Feng SUN; Xi-Qing LI; Sha LU
Journal:  Eur J Dermatol       Date:  2009-06-05       Impact factor: 3.328

3.  Treatment of chromoblastomycosis with terbinafine: a report of four cases.

Authors:  Z Xibao; L Changxing; L Quan; H Yuqing
Journal:  J Dermatolog Treat       Date:  2005-04       Impact factor: 3.359

4.  On the priority of description of chromomycosis.

Authors:  R M Castro; L G Castro
Journal:  Mykosen       Date:  1987-09

5.  Successful treatment of chromoblastomycosis with itraconazole.

Authors:  R Yu
Journal:  Mycoses       Date:  1995 Jan-Feb       Impact factor: 4.377

6.  Molecular ecology and pathogenic potential of Fonsecaea species.

Authors:  G S De Hoog; D Attili-Angelis; V A Vicente; A H G Gerrits Van Den Ende; F Queiroz-Telles
Journal:  Med Mycol       Date:  2004-10       Impact factor: 4.076

7.  Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.

Authors:  Junmin Zhang; Liyan Xi; Changming Lu; Xiqing Li; Ting Xie; Hui Zhang; Zhi Xie; Sybren De Hoog
Journal:  Mycoses       Date:  2008-06-21       Impact factor: 4.377

8.  Chromoblastomycosis caused by a meristematic mutant of Fonsecaea monophora.

Authors:  Liyan Xi; Changming Lu; Jiufeng Sun; Xiqing Li; Honfang Liu; Junmin Zhang; Zhi Xie; G S De Hoog
Journal:  Med Mycol       Date:  2008-09-15       Impact factor: 4.076

Review 9.  Photodynamic therapy in dermatology--an update 2008.

Authors:  Annette Klein; Philipp Babilas; Sigrid Karrer; Michael Landthaler; Rolf-Markus Szeimies
Journal:  J Dtsch Dermatol Ges       Date:  2008-04-09       Impact factor: 5.584

10.  Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.

Authors:  Tânia S Andrade; Luiz G M Castro; Ricardo S Nunes; Viviane M F Gimenes; Arlete E Cury
Journal:  Mycoses       Date:  2004-06       Impact factor: 4.377

View more
  16 in total

1.  The bright future of darkness--the rising power of black fungi: black yeasts, microcolonial fungi, and their relatives.

Authors:  G Sybren de Hoog; Vania A Vicente; Anna A Gorbushina
Journal:  Mycopathologia       Date:  2013-05-29       Impact factor: 2.574

Review 2.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 3.  CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE.

Authors:  Flavio Queiroz-Telles
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015-09       Impact factor: 1.846

4.  High-resolution melting analysis assay for identification of Fonsecaea species.

Authors:  Minglan Shi; Xiqing Li; Jiao Feng; Shulin Jia; Xing Xiao; Chunmei Chen; Cindy Fransisca; Liyan Xi; Junmin Zhang
Journal:  J Clin Lab Anal       Date:  2017-05-22       Impact factor: 2.352

5.  Chromoblastomycosis due to Fonsecaea monophora in a man with nephritic syndrome.

Authors:  Huan Tan; Yan Xu; Xue-Mei Lan; Ya-Guang Wu; Cun-Jian Zhou; Xi-Chuan Yang
Journal:  Mycopathologia       Date:  2015-01-10       Impact factor: 2.574

6.  Pathogenicity and Growth Conditions Modulate Fonsecaea Extracellular Vesicles' Ability to Interact With Macrophages.

Authors:  Lucas de Oliveira Las-Casas; Clara Luna Freitas Marina; Raffael Júnio Araújo de Castro; Luísa Coutinho Coelho; Sônia Nair Báo; G Sybren de Hoog; Vânia Aparecida Vicente; Larissa Fernandes; Anamelia Lorenzetti Bocca
Journal:  Front Cell Infect Microbiol       Date:  2022-06-09       Impact factor: 6.073

Review 7.  Challenges in the therapy of chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Daniel Wagner de C L Santos
Journal:  Mycopathologia       Date:  2013-05-02       Impact factor: 2.574

8.  Antimicrobial and immunomodulatory responses of photodynamic therapy in Galleria mellonella model.

Authors:  Xiaowen Huang; Meinian Xu; Wen Pan; Menglei Wang; Xiaoyan Wu; Siqi Dai; Li Li; Kang Zeng
Journal:  BMC Microbiol       Date:  2020-07-06       Impact factor: 3.605

9.  Hidden under a Cauliflower-Like Skin Tumor: Chromoblastomycosis.

Authors:  B Jakopp; B Stamm; D Eyer; A Conen
Journal:  Case Rep Infect Dis       Date:  2013-06-20

10.  Indoor wet cells as a habitat for melanized fungi, opportunistic pathogens on humans and other vertebrates.

Authors:  Xiaofang Wang; Wenying Cai; A H G Gerrits van den Ende; Junmin Zhang; Ting Xie; Liyan Xi; Xiqing Li; Jiufeng Sun; Sybren de Hoog
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.